test

Barbara Fiorini Due

@Novo Holdings A S

Latest period2024 - Q3ReportedManaged Assets$2.013BTotal holdings37
Assets growth rate8.55%Assets growth rate (2-Q avg)18.26%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Novo Holdings A S's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 37 positions.

Assets under management

The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.013B in assets, with a quarterly growth rate of 8.55% and a 2-quarter average growth rate of 18.26%. The portfolio is managed by Barbara Fiorini Due, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LNZALanzatech Global Inc
Recent Activity
1.51%
$30.206M
15.815M shares@ $1.92 avg price
BAMBrookfield Asset Managmt Ltd
Recent Activity
1.48%
$29.661M
627,207 shares@ $47.29 avg price
CRGXCargo Therapeutics Inc
Recent Activity
1.42%
$28.487M
1.544M shares@ $18.45 avg price
FOLDAmicus Therapeutics Inc
Recent Activity
1.33%
$26.7M
2.5M shares@ $10.68 avg price
RCKTRocket Pharmaceuticals Inc
Recent Activity
1.01%
$20.317M
1.1M shares@ $18.47 avg price
ZBIOZenas Biopharma Inc
Recent Activity
New Position
0.97%
$19.458M
1.15M shares@ $16.92 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 7.15%
0.81%
$16.215M
1.5M shares@ $10.81 avg price
BPMCBlueprint Medicines Corp
Recent Activity
0.81%
$16.188M
175,000 shares@ $92.5 avg price
VERVVerve Therapeutics Inc
Recent Activity
0.58%
$11.616M
2.4M shares@ $4.84 avg price
LXEOLexeo Therapeutics Inc
Recent Activity
Decreased -22.6%
0.51%
$10.148M
1.123M shares@ $9.04 avg price